Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 noviembre 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL‐FP)

Norihiko Kamioka MD, Yoshimitsu Soga MD, Shoichi Kuramitsu MD, Osamu Iida MD, Keisuke Hirano MD, Kenji Suzuki MD, Daizo Kawasaki MD, Terutoshi Yamaoka MD, Nobuhiro Suematsu MD, Yoshiaki Shintani MD, Yusuke Miyashita MD, Hiroki Takahashi MD, Taketsugu Tsuchiya MD, Norihiko Shinozaki MD, Shinya Okazaki MD, Kenji Ando MD

Objectives: We sought to assess whether balloon angioplasty (BA) alone for small femoropopliteal disease improved the outcome following endovascular therapy as compared with stent implantation.

01 septiembre 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Contrast induced‐acute kidney injury following peripheral angiography with carbon dioxide versus iodinated contrast media: A meta‐analysis and systematic review of current literature

Saad S. Ghumman MD, Jonathan Weinerman BS, Aazib Khan MD, Mubeen S. Cheema MD, Marlene Garcia MD, Daniel Levin MD, Rajeev Suri MD, Anand Prasad MD, FACC, FSCAI, RPVI

Objective: We conducted a meta‐analysis to compare the incidence of acute kidney injury (AKI) with carbon dioxide (CO2) versus iodinated contrast media (ICM).

01 junio 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Patient‐level meta‐analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation

Krishna J. Rocha‐Singh MD, Joshua A. Beckman MD, Gary Ansel MD, Sean P. Lyden MD, Peter Schneider MD, Manish Mehta MD, Michael Dake MD, Christopher M. Mullin MS, Michael R. Jaff DO

The factors that impact the clinical effectiveness of bare nitinol stents in claudicants with symptomatic femoropopliteal atherosclerosis are incompletely known. The authors analyzed variables that may influence stent durability and provide a benchmark for their effectiveness. Data analyzed from six studies (999 patients) included baseline noninvasive hemodynamic tests, angiographic characteristics, ultrasound defined stent patency and target lesion revascularization through 12‐months. Baseline ankle‐brachial index and lesion length predicted stent patency and target lesion revascularization and when combined interacted significantly to better predict outcomes. This meta‐analysis provides an important comparator against which emerging therapies that treat claudicants with femoropopliteal atherosclerosis can be assessed.

01 junio 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. SUPERB final 3‐year outcomes using interwoven nitinol biomimetic supera stent

Lawrence A. Garcia MD, Kenneth R. Rosenfield MD, Christopher D. Metzger MD, Frank Zidar MD, Ashish Pershad MD, Jeffrey J. Popma MD, Margo Zaugg RN, Michael R. Jaff DO, on behalf of the SUPERB investigators

Importance: Long‐term outcomes of an interwoven nitinol stent design represent the best in class for treatment of lower limb arterial obstructive disease.

01 febrero 2018

INTERNATIONAL JOURNAL OF CARDIOLOGY. Minimally invasive percutaneous transluminal renal artery stenting

Ken Kongoji, Takanobu Mitarai, Mizuho Kasahara, Hiroshi Yamazaki, Yuki Ishibashi, Kohei Koyama, Kihei Yoneyama, Yasuhiro Tanabe, Yoshihiro J. Akashi, Hideaki Yoshino

Background: Minimally invasive percutaneous transluminal renal artery stenting (MIPTRS) is a method that prevents complications to the greatest extent possible. The present study aimed to investigate the safety and efficacy of MIPTRS performed in cases of renal artery stenosis with an estimated glomerular filtration rate (eGFR) ≤ 45 mL/min.

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Impact of analysis interval size on the quality of optical frequency domain imaging assessments of stent implantation for lesions of the superficial femoral artery

Kojiro Miki MD, Kenichi Fujii MD, Daizo Kawasaki MD, Masahiko Shibuya MD, Masashi Fukunaga MD, Takahiro Imanaka MD, Hiroto Tamaru MD, Akinori Sumiyoshi MD, Machiko Nishimura MD, Tetsuo Horimatsu MD, Ten Saita MD, Yuhei Kobayashi MD, Yasuhiro Honda MD, Peter J. Fitzgerald MD, Tohru Masuyama MD, Masaharu Ishihara MD

01 marzo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Temporal trends in peripheral arterial interventions: Observations from the blue cross blue shield of Michigan cardiovascular consortium (BMC2 PVI)

Michael P. Thomas MD, Yeo Jung Park PhD, Scott Grey PhD, Theodore L. Schreiber MD, Hitinder S. Gurm MD, Dale Leffler DO, Thomas P. Davis MD, Peter Henke MD, Paul Michael Grossman MD

Background: There is little data on indication, vascular beds treated and devices utilized for peripheral arterial interventions.

01 abril 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Proximal balloon occlusion versus distal filter protection in carotid artery stenting: A meta analysis and review of the literature

Jad Omran MD, Ehtisham Mahmud MD, Christopher J. White MD, Herbert D. Aronow MD, MPH, Douglas E. Drachman MD, William Gray MD, Obai Abdullah MD, Mazen Abu-Fadel MD, Belal Firwana MD, Gergory Mishkel MD, Ashraf S. Al-Dadah MD

Introduction: Carotid artery stenting (CAS) is typically performed using embolic protection devices (EPDs) as a means to reduce the risk of procedure related stroke. In this study, we compared procedural morbidity and mortality associated with distal (D-EPD) vs. proximal (P-EPD) protection.

01 mayo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Stent placement in the superficial femoral and proximal popliteal arteries with the innova self-expanding bare metal stent system

Richard J. Powell MD, Michael R. Jaff DO, Herman Schroë MD, Andrew Benko MD, Juan Diaz-Cartelle MD, Stefan Müller-Hülsbeck MD

Objectives: The SuperNOVA trial was designed to evaluate performance of the Innova Vascular Self-Expanding Stent System (Boston Scientific, Marlborough, MA) for treating lesions in the femoropopliteal arteries.

01 mayo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Midterm outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease

T. Raymond Foley MD, Ryan P. Cotter MD, Damianos G. Kokkinidis MD, Daniel D. Nguyen MD, Stephen W. Waldo MD, Ehrin J. Armstrong MD, MSC, FSCAI

Purpose: To assess the intraprocedural and midterm outcomes of orbital atherectomy (OA) combined with drug-coated balloon (DCB) angioplasty for the treatment of calcified femoropopliteal disease.

01 febrero 2017

AMERICAN HEART JOURNAL. Predicting long-term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status Index

Vichai Senthong MD, Yuping Wu PhD, Stanley L Hazen MD, PhD, W. H. Wilson Tang MD

Background: The ability of a simple self-assessment tool for estimated functional capacity to predict long-term prognosis in patients with established peripheral artery disease (PAD) is unknown. We investigate whether subjective measurement of functional capacity estimated by using the Duke Activity Status Index (DASI) questionnaire predicts long-term prognosis in patients with established PAD.

01 diciembre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Endovascular closure of thoracic aortic pseudoaneurysms: A combined device occlusion and coil embolization technique in patients unsuitable for surgery or stenting

Stephen M. Lyen MBBS, FRCR, Jonathan C.L. Rodrigues BSc (Hons), MBChB (Hons), MRCP, FRCR, Nathan E. Manghat MBChB, MRCP, FRCR, MD, FSCCT, Mark C.K. Hamilton MBChB, MRCP, FRCR, Mark Turner MB, ChB (HONS), PhD, FRCP

Objectives: Our aim was to retrospectively evaluate non-stent graft closure of ascending aortic pseudoaneurysms at our center over a 10-year period, and describe a combined device occlusion and coil embolization technique.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.